Drug profile · INN
eflornithine
IFINWIL
eflornithine (IFINWIL) is a ornithine decarboxylase inhibitor. Associated with Norgine Pty..
EMA: approved TGA: approved Antineoplastic and immunomodulating agents (L01) L01XX79
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — eflornithine
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
eflornithine (IFINWIL) is a ornithine decarboxylase inhibitor. Associated with Norgine Pty..
Key facts
INN eflornithine
Brand IFINWIL
Mechanism Ornithine decarboxylase inhibitor
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XX79
Originator Norgine Pty.
Mechanism of action
Ornithine decarboxylase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is eflornithine?
eflornithine (IFINWIL) is a ornithine decarboxylase inhibitor. Associated with Norgine Pty..
What is the brand name for eflornithine?
IFINWIL is a marketed brand name for eflornithine. Check FDA Drugs@FDA for the current US label holder and prescribing information.